Completed PHASE3 INTERVENTIONAL 2-arm NCT01528332

Blue Light Device for Pain Therapy (PAINCT02)

A Prospective, Randomized, Controlled, Double-Blind, Multi-Centre Study to Evaluate the Efficacy and Safety of Blue Light Therapy for Relief of Chronic Musculoskeletal Back Pain

Sponsor: Philips Electronics Nederland BV

Conditions Chronic Pain Low Back Pain Low Back Pain, Recurrent Musculoskeletal Pain

Interventions Control PRP device Pain Relief Patch

Updated 9 times since 2017 Last updated: Feb 7, 2014 Started: Feb 29, 2012 Primary completion: Aug 31, 2012 Completion: Aug 31, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Chronic Pain and Low Back Pain and is currently completed. Philips Electronics Nederland BV leads this study, which shows 9 recorded versions since 2012 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2023 — Jul 2024 [monthly]

Completed PHASE3
Dec 2022 — Jan 2023 [monthly]

Completed PHASE3
Jan 2021 — Dec 2022 [monthly]

Completed PHASE3

▶ Show 4 earlier versions

May 2019 — Jan 2021 [monthly]

Completed PHASE3
Jun 2018 — May 2019 [monthly]

Completed PHASE3
May 2017 — Jun 2018 [monthly]

Completed PHASE3
Jan 2017 — May 2017 [monthly]

Completed PHASE3

First recorded

Feb 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Philips Electronics Nederland BV

Data source: Philips Electronics Nederland BV

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Heidelberg, Germany
• Mannheim, Germany